Publication | Open Access
Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa®
31
Citations
20
References
2019
Year
MedicineAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyPharmacotherapyAntiviral DrugPharmacologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1